371 related articles for article (PubMed ID: 31927332)
21. Cross-presentation of Exogenous Antigens.
Li B; Hu L
Transfus Clin Biol; 2019 Nov; 26(4):346-351. PubMed ID: 30797678
[TBL] [Abstract][Full Text] [Related]
22. Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens.
Maecker HT; Ghanekar SA; Suni MA; He XS; Picker LJ; Maino VC
J Immunol; 2001 Jun; 166(12):7268-75. PubMed ID: 11390476
[TBL] [Abstract][Full Text] [Related]
23. Distinct Subcellular Compartments of Dendritic Cells Used for Cross-Presentation.
Imai J; Otani M; Sakai T
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717517
[TBL] [Abstract][Full Text] [Related]
24. Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8
Murata Y; Kawashima K; Sheikh K; Tanaka Y; Isogawa M
J Virol; 2018 Nov; 92(21):. PubMed ID: 30089700
[TBL] [Abstract][Full Text] [Related]
25. Autophagy-related protein Vps34 controls the homeostasis and function of antigen cross-presenting CD8α
Parekh VV; Pabbisetty SK; Wu L; Sebzda E; Martinez J; Zhang J; Van Kaer L
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):E6371-E6380. PubMed ID: 28716903
[TBL] [Abstract][Full Text] [Related]
26. Cross-presentation in viral immunity and self-tolerance.
Heath WR; Carbone FR
Nat Rev Immunol; 2001 Nov; 1(2):126-34. PubMed ID: 11905820
[TBL] [Abstract][Full Text] [Related]
27. Pathways of MHC I cross-presentation of exogenous antigens.
Cruz FM; Chan A; Rock KL
Semin Immunol; 2023 Mar; 66():101729. PubMed ID: 36804685
[TBL] [Abstract][Full Text] [Related]
28. Recent developments in MHC-class-I-mediated antigen presentation.
Lehner PJ; Cresswell P
Curr Opin Immunol; 2004 Feb; 16(1):82-9. PubMed ID: 14734114
[TBL] [Abstract][Full Text] [Related]
29. Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I.
Horrevorts SK; Duinkerken S; Bloem K; Secades P; Kalay H; Musters RJ; van Vliet SJ; García-Vallejo JJ; van Kooyk Y
Front Immunol; 2018; 9():1231. PubMed ID: 29963041
[TBL] [Abstract][Full Text] [Related]
30. Are ERAD components involved in cross-presentation?
Grotzke JE; Cresswell P
Mol Immunol; 2015 Dec; 68(2 Pt A):112-5. PubMed ID: 26005101
[TBL] [Abstract][Full Text] [Related]
31. Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming: a new role for lymphatic endothelial cells.
Hirosue S; Vokali E; Raghavan VR; Rincon-Restrepo M; Lund AW; Corthésy-Henrioud P; Capotosti F; Halin Winter C; Hugues S; Swartz MA
J Immunol; 2014 Jun; 192(11):5002-11. PubMed ID: 24795456
[TBL] [Abstract][Full Text] [Related]
32. The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells.
Tran KK; Shen H
Biomaterials; 2009 Mar; 30(7):1356-62. PubMed ID: 19091401
[TBL] [Abstract][Full Text] [Related]
33.
Del Balzo D; Capmany A; Cebrian I; Damiani MT
Front Immunol; 2021; 12():662096. PubMed ID: 33936099
[TBL] [Abstract][Full Text] [Related]
34. IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing.
Spadaro F; Lapenta C; Donati S; Abalsamo L; Barnaba V; Belardelli F; Santini SM; Ferrantini M
Blood; 2012 Feb; 119(6):1407-17. PubMed ID: 22184405
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.
Schaible UE; Winau F; Sieling PA; Fischer K; Collins HL; Hagens K; Modlin RL; Brinkmann V; Kaufmann SH
Nat Med; 2003 Aug; 9(8):1039-46. PubMed ID: 12872166
[TBL] [Abstract][Full Text] [Related]
36. Bioorthogonal deprotection on the dendritic cell surface for chemical control of antigen cross-presentation.
Pawlak JB; Gential GP; Ruckwardt TJ; Bremmers JS; Meeuwenoord NJ; Ossendorp FA; Overkleeft HS; Filippov DV; van Kasteren SI
Angew Chem Int Ed Engl; 2015 May; 54(19):5628-31. PubMed ID: 25784151
[TBL] [Abstract][Full Text] [Related]
37. Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation.
Cohn L; Chatterjee B; Esselborn F; Smed-Sörensen A; Nakamura N; Chalouni C; Lee BC; Vandlen R; Keler T; Lauer P; Brockstedt D; Mellman I; Delamarre L
J Exp Med; 2013 May; 210(5):1049-63. PubMed ID: 23569326
[TBL] [Abstract][Full Text] [Related]
38. Cross-presentation of antigens by dendritic cells.
Belz GT; Carbone FR; Heath WR
Crit Rev Immunol; 2002; 22(5-6):439-48. PubMed ID: 12803320
[TBL] [Abstract][Full Text] [Related]
39. Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy.
Moussion C; Delamarre L
Semin Immunol; 2024 Feb; 71():101848. PubMed ID: 38035643
[TBL] [Abstract][Full Text] [Related]
40. Processing of bacterial antigens for peptide presentation on MHC class I molecules.
Wick MJ; Ljunggren HG
Immunol Rev; 1999 Dec; 172():153-62. PubMed ID: 10631944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
